- Suppliers
ADM 
Armor Pharma 
Asahi KASEI 
Ashland 
BASF 
Beneo 
Budenheim 
Captisol 
Clariant 
Croda 
DFE Pharma 
Excipio Chemicals 
Fuji Chemical 
Gattefossé 
Gangwal 
IamFluidics 
IOI Oleo 
Ingredient Pharm 
JRS Pharma 
Kerry 
KLK Oleo 
Lipoid 
Lubrizol Life Science Health 
MAGNESIA 
MEGGLE 
Nagase Viita 
Nordic Bioproducts 
Pfanstiehl 
pharm-a-spheres 
PMC Isochem 
Seppic 
ShinEtsu 
Sigachi 
SPI Pharma 
Südzucker 
Vikram Thermo 
Zerion Pharma 
All4Nutra
- Suppliers
ADM Armor Pharma Asahi KASEI Ashland BASF Beneo Budenheim Captisol Clariant Croda DFE Pharma Excipio Chemicals Fuji Chemical Gattefossé Gangwal IamFluidics IOI Oleo Ingredient Pharm JRS Pharma Kerry KLK Oleo Lipoid Lubrizol Life Science Health MAGNESIA MEGGLE Nagase Viita Nordic Bioproducts Pfanstiehl pharm-a-spheres PMC Isochem Seppic ShinEtsu Sigachi SPI Pharma Südzucker Vikram Thermo Zerion Pharma - All4Nutra
Webinar: Excipient Selection for Enhancing Bioavailability and Stability in Oral and Injectable Drug Formulations
Excipient Selection for Enhancing Bioavailability and Stability in Oral and Injectable Drug Formulations
See our next webinar on the topic of:
Excipient Selection for Enhancing Bioavailability and Stability in Oral and Injectable Drug Formulations
Description:
Excipient impurities causing stability failures? Formulation inconsistencies delaying your launch? Visual quality issues impacting patient confidence?
Join the webinar to discover why excipient selection from day one is critical to your formulation success and how advanced purification technologies can eliminate the hidden risks that compromise drug product quality.
Excipient quality extends beyond compendial specifications. Explore smart selection strategies for complex formulations with poorly water-soluble APIs. Prevent impurity-driven interactions that compromise stability and ensure consistent performance through commercial scale. See breakthrough purification technology achieving up to 54% reduction in color formation while maintaining full functionality.
Why Attend?
- Start right: Make informed excipient choices early in development
- Reduce risk: Prevent stability failures and batch rejections
- Accelerate timelines: Avoid costly reformulation and launch delays
- Build confidence: Deliver consistent, high-quality products patients trust
Perfect For:
- Formulation scientists
- QA/Regulatory professionals
- R&D managers
- CMC specialists
- Technical decision-makers in pharma and biopharma development
What you will learn:
- How excipient impurities can influence drug product stability, discoloration, and degradation pathways
- Practical strategies for selecting excipients in complex formulations, especially for poorly water-soluble APIs
- How excipient purity impacts visual consistency, stability, and manufacturability of drug products
- How advanced purification technologies can help mitigate formulation risks
Date & Time & Timezone: Apr 22, 2026 04:00 PM in Amsterdam, Berlin, Rome, Stockholm, Vienna
For more information & registration here:
Speaker:
Dr. Bhushan Thekedar
Head of Global Business Development, Clariant
Dr. Bhushan Thekedar is Head of Global Business Development for Healthcare at Clariant, where he leads global commercial strategy and growth initiatives for pharmaceutical excipients.
With over 15 years of experience in the life sciences industry, he has held technical and commercial leadership roles at Clariant, Merck KGaA, and BASF, focusing on formulation excipients, bioavailability enhancement technologies, and pharmaceutical ingredient solutions.
Dr. Thekedar combines a strong scientific background with global business development expertise and works closely with pharmaceutical companies to support the development of robust and high-performance drug formulations.
For more information & registration here:
Source: Dr. Bhushan Thekedar, Clariant, Pharma Excipients, webinar Excipient Selection for Enhancing Bioavailability and Stability in Oral and Injectable Drug Formulations
Related Posts
